Monthly Archives: October 2009

Needle exchange, prevention and return on investment

It’s been a substantive week for the ATOD sector from a government policy viewpoint, with the release of the Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs in Australia 2009 report by the Commonwealth Department of Health and Aging and the steady progress towards realisation of a nationwide Preventative Health Agency.

For those working at the NSEP coalface the Commonwealth report doesn’t contain any great surprises: the program has saved hundreds of millions of dollars overs its lifetime (Alex Wodak has a спалниnice piece over at Crikey on the report). The challenge now falls to both the Commonwealth and State governments to follow-through and further entrench the validity of NSEP. Hell, they could even expand its reach. There’s a chance for some governmental innovation.

The Health Minister Nicola Roxon is enthused by the passage of the legislation supporting the formation of a preventative health agency. Not surprisingly, the pressure is already being applied to Senators in regards to its passage through that chamber. The press release in full:

Australia’s first ever Preventive Health Agency will soon be established following the passage of important legislation in the House of Representatives today. The Agency is a key part of the Rudd Government’s decision to invest more in preventative health measures than any other government in Australia’s history.

The legislation is now with the Senate for consideration. It is essential that this Bill be passed without delay so that the agency can commence work on 1 January 2010.

The creation of this agency responds to calls from health professionals for Australia to establish – as many other countries have done – a dedicated agency to focus exclusively on driving the prevention agenda and combat the complex challenges of preventable chronic disease.

The agency will guide health ministers in their task of curbing the growth of lifestyle risks driving chronic disease. It is a role requiring national leadership, capacity to work across sectors and portfolios, and an oversight role for surveillance and monitoring.

The agency will bring together the best expertise in the country and play a key role in gathering, analysing and disseminating the best available evidence and evidence-based programs.

Its prevention activities will engage all Australian governments as well as employers, businesses and other sectors, to benefit every community in the nation.

The new preventive health agency will concentrate on reducing the burden that preventable health problems are already placing on the workforce, and ensure Australia’s productive capacity is maintained.

The agency will receive $133 million over four years, from the Government’s record $872 million COAG Prevention Partnership funding.

Strong support for the agency has been expressed by key players in the preventive health field such as the Public Health Association of Australia, and this is important in ensuring the agency’s success in forging cohesiveness in national preventive health efforts.

The preventative health agency legislation holds some promise and it’ll be interesting to see how much ideology enters the debate. You can expect the AMA to go in hard on the issue of medical funding not beign sacrificed on the altar of prevention. There may also be some argy bargy over the taskforce being another incremental step toward Commonwealth takeover of health. Beyond that, it’s really hard to see any Senator taking a strong stand unless it’s to claim the model is wrong or that there’s not enough funding for it to work effectively.

Over to you: are you encouraged by the NSEP report and the taskforce legislation? Do you see it as a positive step toward better health services delivery?

NDARC seeks a new Director

It’s fair to say NDARC is one of the dominant ATOD research bodies in Australia, so the recruitment of a new Director is noteworthy at any time. Here’s the brief details:

Director, National Drug and Alcohol Research Centre
Faculty of Medicine
REF. 6753

UNSW is one of Australia’s leading research and teaching universities, with a particular commitment to fundamental and applied research, social engagement and an international perspective. The National Drug and Alcohol Research Centre, located in the Faculty of Medicine is committed to providing a stimulating research environment that promotes excellence and innovation in drug and alcohol research. NDARC is a Commonwealth funded National Research Centre with an outstanding record of success in obtaining peer-reviewed research funding and an international reputation as a leading research centre in drug and alcohol related issues.

The Faculty is now seeking to appoint a new Director (at the academic level of Professor or Associate Professor) who will build on the impressive growth of the Centre over the past 5 years and raise its profile even higher on the National and International stage.

As an internationally recognized academic with an established research profile in drug and alcohol studies, you will bring the following to the role:
A breadth of vision that encompasses the diverse range of drug and alcohol research within the Centre;
A profile in the field that will attract outstanding talent to the Centre and inspire new approaches to drug and alcohol research;
Leadership and change management expertise to further develop what is already a dynamic and productive culture in the Centre, and to continue its growth trajectory;
Willingness and ability to actively promote the best interests of the Centre, Faculty and University; and
The communication and management skills necessary to take the Centre forward and to represent it and give it a prominent voice in domestic and international forums.

The appointment will be for a full-time five year, potentially renewable term. The Director appointment attracts a salary supplement, and additional benefits may be negotiable.

EEO groups are encouraged to apply. The University reserves the right to fill the position by invitation. Applicants should systematically address the selection criteria contained in the Position Statement.

Membership of an approved University superannuation scheme is a condition of employment for this position. The successful applicant may be required to undertake a criminal record check.

Having read all the documentation you may then direct any enquiries regarding this position to Mr Wayne Bruce, Ccentric Health Executive Search on (612) 9232 8148; wayneb@ccentrichealth.com

Applications close : 30 October 2009

More info on applying here.